» Articles » PMID: 28596261

Kidney Cancer, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology

Abstract

The NCCN Guidelines for Kidney Cancer provide multidisciplinary recommendations for the clinical management of patients with clear cell and non-clear cell renal carcinoma. These guidelines are developed by a multidisciplinary panel of leading experts from NCCN Member Institutions consisting of medical oncologists, hematologists and hematologic oncologists, radiation oncologists, urologists, and pathologists. The NCCN Guidelines are in continuous evolution and are updated annually or sometimes more often, if new high-quality clinical data become available in the interim.

Citing Articles

The impact of indocyanine green on partial nephrectomy perioperative outcomes.

Joffe B, Li G, Gorroochurn P, DeCastro G, Lenis A, McKiernan J J Robot Surg. 2025; 19(1):78.

PMID: 39987334 DOI: 10.1007/s11701-025-02242-3.


Can quantitative perfusion CT-based biomarkers predict renal cell carcinoma subtypes?.

Sah A, Gupta A, Garg S, Yadav N, Ahmad Khan M, Das C Abdom Radiol (NY). 2024; .

PMID: 39688674 DOI: 10.1007/s00261-024-04746-2.


Hsa_circ_0072732 enhances sunitinib resistance of renal cell carcinoma by inhibiting ferroptosis.

Tian X, Liu J, Yi C, You X, Yuan C Discov Oncol. 2024; 15(1):700.

PMID: 39580569 PMC: 11585529. DOI: 10.1007/s12672-024-01580-2.


Machine learning-based multiparametric MRI radiomics nomogram for predicting WHO/ISUP nuclear grading of clear cell renal cell carcinoma.

Yang Y, Zhang Z, Zhang H, Liu M, Zhang J Front Oncol. 2024; 14:1467775.

PMID: 39575426 PMC: 11578869. DOI: 10.3389/fonc.2024.1467775.


Exploring prognostic implications of miRNA signatures and telomere maintenance genes in kidney cancer.

Yerukala Sathipati S, Jeong S, Sharma P, Mayer J, Sharma R, Ho S Mol Ther Oncol. 2024; 32(4):200874.

PMID: 39399813 PMC: 11467672. DOI: 10.1016/j.omton.2024.200874.